Souhaitez-vous accéder aux communiqués récents ?

Precision Medicine Surge: KFSHRC Achieves 39% Rise in Genetic Mutation Analysis

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

Kaerus announces its novel BK channel modulator KER-0193 is safe and well tolerated in Phase 1, also demonstrating proof of mechanism with EEG biomarker.

Lexeo Therapeutics Announces Positive Interim Data for LX1001, First-Ever Gene Therapy to Impact Underlying Genetic Cause of APOE4-Associated Alzheimer's

Austin, TX, USA, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Genetic Engineering Market Size, Trends and Insights By Product (Biochemical,...

WASHINGTON, June 05, 2024 (GLOBE NEWSWIRE) -- Today, the National Council on Disability (NCD) released a first-of-its-kind federal report in which people with certain genetic and heritable...

Late breaking poster presentation includes Phase 1b clinical trial results demonstrating the safety and preliminary efficacy of KM-001, a topical TRPV3 inhibitor, for the treatment of palmoplantar...

Vancouver, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The global protein therapeutics market size was USD 152.28 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.6% during the forecast...

MELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...

Austin, TX, USA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Fermentation Market Size, Trends and Insights By Ingredient (Whey...